Table 2 Variation of some clinical and laboratory data according to peanut sensitization*
From: Peanut sensitization in a group of allergic Egyptian children
Variable | Peanut + (n = 7) | Peanut - (n = 93) | Test | p value |
|---|---|---|---|---|
Age (yr) - median (IQR) | 9.0 (4.00) | 6.0 (4.75) | Z = - 0.225 | 0.221 |
Gender (male/female) | 05/02 | 50/43 | X2 = 0.821 | 0.365 |
Positive family history of allergy (%) | 100% | 75.3% | X2 = 2.248 | 0.134 |
Exclusive BF duration (mo) - median (IQR) | 6.0 (2.0) | 6.0 (2.0) | Z = - 0.071 | 0.943 |
Age of BF stoppage (mo) - median (IQR) | 15.0 (4.0) | 16.0 (6.0) | Z = - 1.211 | 0.226 |
Last peanut consumption (days) - median (IQR) | 5.0 (2.0) | 4.0 (3.0) | Z = -0.807 | 0.420 |
Last antihistamine consumption (days) - median (IQR) | 6.0 (3.0) | 5.0 (4.0) | Z = -1.096 | 0.273 |
AEC (cells/mm3) - median (IQR) | 120.0 (220.0) | 90.0 (62.5) | Z = - 1.935 | 0.053 |
Total IgE (kUA/L) - median (IQR) | 130.0 (136.0) | 113.0 (50.0) | Z = - 1.008 | 0.313 |